This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

5 May 2011

Financial Reports: AMRI 1Q11

AMRI has posted its financial results for the first quarter ended March 31, 2011.

Albany Molecular Research Inc. announced its quarterly results on Wednesday. Total revenue for the first quarter of 2011 was $56.9 million, an increase of 15% compared to total revenue in the first quarter of 2010.


Contract revenue in the quarter was $42.9 million, up 10%.


Discovery Services accounted for $10.6 million, down 15%, Development/Small Scale Manufacturing was $10.5 million, up 24%, and Large Scale Manufacturing brought in $21.8 million, up 22%. Recurring royalties in the quarter were up 34% to $14 million. Loss in the quarter includes $400,000 in costs related to the ongoing resolution of the FDA warning letter pertaining to the Burlington, MA parenteral dosage

Related News